Alcon Inc. (ALC) Fair Value 2026

ALC · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

2.0 /10

32 fundamental signals · 13 models active

Value Trap Risk

(—/100)

Quick Summary — As of 2026-07-13, Alcon Inc. (ALC) trades at $68.99, approximately 144% above CirclFi’s Bayesian DCF fair value of $28.25. QOC: 2.0/10. 13/13 models active.

Key Facts

Ticker
ALC
Price
$68.99
Quality Score
2.0/10
Value Trap Risk
—/100
Models Active
13/13
Last Updated
Strength: First Chicago suggests +3.7% upside with 7% confidence
Risk: Below-average Quality Score of 2.0/10 signals weak fundamentals

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($68.99)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
$28.25 -59.1%
Earnings Power Value
Medium Conviction
$32.59 -52.8%
CUCE Ensemble
Low Conviction
$47.57 -31.0%
First Chicago
Low Conviction
$71.57 +3.7%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is Alcon Inc. (ALC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Alcon Inc.'s intrinsic value is estimated at $52.48, presenting a divided outlook at the current price of $68.99. With an average implied return of -23.9% across a split 3–7 (bull–bear) consensus, the model spread of +130.0% underscores analytical uncertainty. Notably, ML-RIV sees the most upside at +41.6% (fair value: $97.70), while Markov DDM is the most conservative at -88.4% ($8.00). The spread between these extremes — +130.0% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About ALC?

13 of 13 models are currently active for ALC. Of these, 5 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates ALC's intrinsic value at $28.25, implying -59.1% downside from the current price. See which stocks rank higher →

How Does ALC Rank in Medical Instruments & Supplies?

Among 3 Medical Instruments & Supplies stocks, ALC ranks #3 by Quality of Company score. CirclFi's QOC score of 2.0/10 evaluates 32 fundamental signals. A score of 2.0 signals below-average fundamentals.

Alcon Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is ALC a Value Trap?

The Value Trap algorithm is not active for ALC. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for Alcon Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Alcon Inc. earns a quality score of 2.0/10. This concerning rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +130.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ALC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ALC's 13 active models, average confidence is 8%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Alcon Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

2 related Medical Instruments & Supplies stocks with 13-model coverage

Read investment analysis: ALGN · ANGO

Frequently Asked Questions About Alcon Inc.

What is Alcon Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Alcon Inc. (ALC) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $28.25. The Quality of Company score is 2.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ALC overvalued or undervalued right now?

At $68.99, 5 of 13 active models suggest ALC may be undervalued, while 8 indicate potential overvaluation. The assessment depends on which methodology best fits Alcon Inc.'s business model in Medical Instruments & Supplies.

What does a Quality of Company score of 2.0 mean for ALC?

Alcon Inc.'s QOC of 2.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on ALC?

CirclFi analyzes ALC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is ALC a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for ALC at this time. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on ALC.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access